Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABBV compared with MRK: revenue, margins and what each company keeps, and the suppliers and customers both name
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
MRK
Merck & Co., Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABBV
AbbVie Inc.
vs
MRK
Merck & Co., Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 500d
Method
›
Moved together
ABBV
with
MRK
×0.55
co-movement · MRK on ABBV · 500d
r 0.51
scale to r 0.75
Shared co-movers
7
with ABBV
with MRK
AMGN
Amgen Inc
r 0.52
r 0.50
NVS
Novartis AG
r 0.48
r 0.51
PFE
Pfizer Inc
r 0.48
r 0.58
JNJ
Johnson & Johnson
r 0.45
r 0.47
BIIB
Biogen Inc.
r 0.43
r 0.49
BMY
Bristol Myers Squibb Co
r 0.41
r 0.52
ABBV, solid
MRK, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ABBV
AbbVie Inc.
Change
288.78
· pre 288.05
· delayed
Mkt cap
$521.1B
Revenue
$17.0B
Q2 FY26
Revenue
$61.2B
FY25
MRK
Merck & Co., Inc.
Change
148.44
· pre 147.85
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$366.0B
Revenue
$16.6B
Q2 FY26
Revenue
$65.0B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
ABBV
AbbVie Inc.
vs
MRK
Merck & Co., Inc.
288.78
pre 288.05
delayed
Price
148.44
pre 147.85
delayed
$521.1B
Mkt cap
$366.0B
Q2 FY26
$17.0B
Revenue
$16.6B
Q2 FY26
FY25
$61.2B
Revenue
$65.0B
FY25
Change
Change
ABBV
288.78
vs
MRK
148.44
Pre-market
Nov 3 '26
delayed